Concepedia

Rachael L. Metheringham

RL

Statistics

Publications

22

Citations

757

H-Index

16

Active since

1995

Affiliations

University of Nottingham(Current)

Nottingham City Hospital

Nottingham Trent University

University of Birmingham

Juntendo University

Rachael L. Metheringham is an author at University of Nottingham specializing in immunology, oncology, and cancer immunotherapy.

ORCID

Publications per year

1995–2022

22

Publications

22

Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell–Mediated Antitumor Immunity

Victoria A. Brentville, Rachael L. Metheringham, Barbara Gunn et al. · Cancer Research · 2016 · 104 citations · Full text

, , +17

Effects of mutations in genes for proteins involved in disulphide bond formation in the periplasm on the activities of anaerobically induced electron transfer chains in Escherichia coli K12

Rachael L. Metheringham, Kerry Tyson, Helen Crooke et al. · Molecular and General Genetics MGG · 1996 · 61 citations

, , +16

An essential role for DsbA in cytochromec synthesis and formate-dependent nitrite reduction byEscherichia coli K-12

Rachael L. Metheringham, Lesley Griffiths, Helen Crooke et al. · Archives of Microbiology · 1995 · 59 citations

, , +8

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses

Victoria A. Brentville, Rachael L. Metheringham, Ian Daniels et al. · Journal for ImmunoTherapy of Cancer · 2020 · 53 citations · Full text

, , +17

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial

Poulam M. Patel, Christian H. Ottensmeier, C Mulatero et al. · OncoImmunology · 2018 · 47 citations · Full text

, , +17

1–5 of 22